Rapid Micro Biosystems EBITDA 2020-2025 | RPID

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Rapid Micro Biosystems ebitda from 2020 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Rapid Micro Biosystems ebitda from 2020 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$180.2B
Intuitive Surgical (ISRG)	$179.4B
Edwards Lifesciences (EW)	$47.6B
IDEXX Laboratories (IDXX)	$46B
Alcon (ALC)	$44B
DexCom (DXCM)	$34.9B
IQVIA Holdings (IQV)	$32.6B
Mettler-Toledo (MTD)	$26.3B
STERIS (STE)	$22.6B
Waters (WAT)	$17.8B
SONOVA HOLDING (SONVY)	$16.4B
Hologic (HOLX)	$14.5B
Sysmex ADR (SSMXY)	$10.4B
Penumbra (PEN)	$9.8B
Masimo (MASI)	$8.5B
Globus Medical (GMED)	$7.2B
Glaukos (GKOS)	$5.4B
Teleflex (TFX)	$5B
Integer Holdings (ITGR)	$3.8B
TransMedics (TMDX)	$3.6B
PROCEPT BioRobotics (PRCT)	$2.8B
LivaNova (LIVN)	$2.4B
Nihon Kohden (NHNKY)	$2B
Elekta AB (EKTAY)	$1.9B
Veracyte (VCYT)	$1.9B
Alphatec Holdings (ATEC)	$1.6B
Artivion (AORT)	$1.3B
Tandem Diabetes Care (TNDM)	$1.1B
Paragon 28 (FNA)	$1.1B
OPKO Health (OPK)	$1.1B